Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Suri Anish | Aug 25, 2023 | Buy | 4,000 | $2.76 | $11,000 |
| PASSERI DANIEL R | Aug 14, 2023 | Buy | 3,000 | $2.86 | $8,600 |
| Kiener Peter A | Mar 23, 2023 | Sell | 9,325 | $3.28 | $31,000 |
What's the latest insider transaction for Cue Biopharma?
The most recent insider transaction for Cue Biopharma was conducted by Suri Anish, who sold 4,000 shares on August 25, 2023 at a price of $2.76 per share.
Which insider bought the most CUE stock over the last two years?
Suri Anish has bought the most CUE stock in the last 2 years, with a total value of $11,000.
Which insider has sold the most CUE stock over the last two years?
Kiener Peter A has sold the most CUE stock in the last 2 years, with a total value of $31,000.
What is the total value of insider transactions for Cue Biopharma (CUE) in the last 2 years?
The total value of insider transactions for Cue Biopharma in the last 2 years is negative, amounting to -$11,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Cue Biopharma's market confidence?
Over the last 2 years, insider transactions for Cue Biopharma have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
